Company Profile
iPreg Inc., established in 2018, is a biomedical device manufacturer specializing in reproductive medicine. Utilizing the physiological characteristics of sperm, we have developed an advanced sperm sorting device designed to improve sperm quality, supporting infertility treatments and enhancing pregnancy success rates.
With infertility affecting approximately 15% of the global population, iPreg’s technology represents a significant advancement in assisted reproductive techniques. Our Sperm Sorting Chip can increase the proportion of healthy sperm to 90% within 30 minutes. This efficient, safe, and effective process enhances sperm recovery, optimizing the critical step of sperm selection in in vitro fertilization (IVF), ultimately improving the success rates of assisted reproduction.
Milestones
2018
・
iPreg Founded
・
Taiwan SPARK TAIWAN Team 2018
・
The 16th National Innovation Award in Taiwan
・
Runner-up in the Third Taiwan Commercial Exchange Society Innovation and Entrepreneurship Contest
2019
・
Taiwan Ministry of Science and Technology Future Technology Breakthrough Award
・
The 17th Taiwan National Innovation Award
・
Successfully Complete a 1 million US dollar Fundraising Campaign
2020
・
Bootcamp Third place
・
First Prize in the Taiwan Innovation and Entrepreneurship Incentive Program (FITI).
・
Linkou Startup Park International Entrepreneurship Competition Global Hack Startup Award
2021
・
InnoVex global final top ten
・
X-pitch ranked top 150 globally (out of 3680 teams worldwide)
2022
・
Meet Neo Star Annual Outstanding New Startups
2023
・
Passed ISO13485:2016 Certification for Medical Device
2024
・
Selected for the Taiwan-Berkeley Cohort 4, Berkeley Health Innovation Accelerator
・
Successfully Complete a 2 million US dollar Fundraising Campaign
・
Secured Certification from TFDA
Dr. Chen-Yen Chung
Founder & CEO
PhD in Immunology from the University of Edinburgh, UK. He studied autoimmune diseases at the Institute of Biomedicine, Academia Sinica from 2009 to 2015, and served as an adjunct assistant professor in the Department of Microbiology at Soochow University. In 2013, Dr. Chung founded Medoc Incorporation specialized in the research and development, manufacturing and sales of health and beauty products. Dr. Chung founded iPreg Incorporation and the core technology is to implement flow cytometry technology with micro-channel chips.
Dr. Ching-Wen Chang
Director of Research and Development
Dr. Ching-Wen Chang holds a PhD in medicine from the University of Edinburgh, UK. She joined iPreg Inc. in October 2020 and currently oversees all medical device development activities, including process development and regulatory affairs.
Prior to joining iPreg Inc., Dr. Chang was a Senior Scientist at Synermore Inc., a company dedicated to the research and development of innovative biologics. There, she played a pivotal role in the development of Biologics and the Investigational New Drug (IND) regulatory submissions for several pipeline products.
Dr. Bor-Ran Li
CTO
Ph.D. in Chemistry, University of Edinburgh, UK. He is a assistant professor at the biomedical Institute of National Yang Ming Chiao Tung University. He specializes in nanomaterial synthesis, sensor component production, biochip integration, microfluidic cell sorting and clinical biomedical assessment.
Dr. Bo-Yong Chu
Management Mentor
Ph.D. in business administration from Purdue University, professor of management science department of National Chao Tong University, founder of National Chiao Tung University EMBA, academician of the science and technology management society of the Republic of China.
Dr. Ming-I Hsu
Medical Mentor
Professor of department of medicine, Taipei Medical University, director of WanFang Hospital in obstetrics and gynecology department, Taipei Medical University, and dean of HUAYU Fertility Center.
